Butamirate Explained

Butamirate (or brospamin, trade names Acodeen, Codesin, Pertix, Sinecod, Sinecoden, Sinecodix) is a cough suppressant.[1] It has been marketed in Europe and Mexico, but not in the United States.[2]

It is sold in the form of lozenges, syrup, tablets, dragées, or pastilles as the citrate salt. Adverse effects can include nausea, diarrhea, vertigo, and exanthema.[2]

Pharmacology

A study found it to bind to the cough center in the medulla oblongata, more specifically the dextromethorphan-binding site in guinea pig brain with high affinity.[3]

As a 2-(2-diethylaminoethoxy)ethyl ester, it is chemically related to oxeladin and pentoxyverine, which are in the same class. (Oxeladin has an additional ethyl group in its carboxylic acid, pentoxyverine has both ethyl groups of oxeladin replaced by one cyclopentyl in the same place.)

See also

Notes and References

  1. Germouty J, Weibel MA . [Clinical comparison of butamirate citrate with a codeine-based antitussive agent] . Revue Médicale de la Suisse Romande . 110 . 11 . 983–6 . November 1990 . 1980027 .
  2. Book: 0-8103-7177-4 . Drugs Available Abroad, 1st Edition . 29–30 . 1991 . Schlesser JL . Derwent Publications Ltd..
  3. Klein M, Musacchio JM . High affinity dextromethorphan binding sites in guinea pig brain. Effect of sigma ligands and other agents . The Journal of Pharmacology and Experimental Therapeutics . 251 . 1 . 207–15 . October 1989 . 2477524 .